©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
A Novel Phosphatidylserine-binding Peptide Motif Defined by an Anti-idiotypic Monoclonal Antibody
LOCALIZATION OF PHOSPHATIDYLSERINE-SPECIFIC BINDING SITES ON PROTEIN KINASE C AND PHOSPHATIDYLSERINE DECARBOXYLASE (*)

(Received for publication, September 5, 1995; and in revised form, October 9, 1995)

Koji Igarashi (1) Mizuho Kaneda (1) Akiko Yamaji (3) Takaomi C. Saido (2) Ushio Kikkawa (4) Yoshitaka Ono (5) Keizo Inoue (3) Masato Umeda (1)(§)

From the  (1)Department of Inflammation Research and (2)Department of Molecular Biology, The Tokyo Metropolitan Institute of Medical Science (Rinshoken), 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113, Japan, (3)Department of Health Chemistry, Faculty of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan, (4)Biosignal Research Center, Kobe University, 1-1 Rokkodai, Nada-ku, Kobe 657, Japan, and (5)Department of Biology, Faculty of Science, Kobe University, Kobe 657, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

A monoclonal anti-idiotypic antibody, Id8F7, previously shown to bind to a phosphatidylserine (PS)-specific binding site on protein kinase C (PKC) has been used to identify a 12-amino acid consensus sequence shared by PKC and phosphatidylserine decarboxylase (PSD). The 14-amino acid synthetic peptide derived from the corresponding region of PSD (amino acids 351-364 of the enzyme from Chinese hamster ovary cells) bound effectively and specifically to PS, and that derived from rat PKC (amino acids 227-240) bound weakly but specifically to PS. Analysis of binding of Id8F7 to various synthetic peptides revealed that the consensus sequence motif, FXFXLKXXXKXR, is responsible for the interaction with both Id8F7 and PS. The results suggest that the conserved amino acid residues represent a basic structural motif for the specific interaction with PS, and the corresponding regions of PKC and PSD form the PS-specific binding sites of these enzymes.


INTRODUCTION

Although it is generally accepted that phospholipids in membranes are essential for the catalytic activity of many membrane-bound enzymes, it is still unclear how phospholipids regulate the activity of the enzymes. Phosphatidylserine (PS) (^1)in membranes is known to be an essential cofactor for the activation of protein kinase C (PKC) (1, 2, 3) and blood coagulation(4, 5, 6) . Recent analyses have shown that it regulates the activity of various enzymes such as c-Raf-1 protein kinase(7) , nitric oxide synthase(8) , Na/K-ATPase(9) , Dynamin GTPase(10) , and diacylglycerol kinase (11) and acts as a ligand in recognition of apoptotic cells(12, 13) . PKC is a family of phospholipid-dependent kinases, and its enzymatic activity is allosterically regulated by 1,2-diacyl-sn-glycero-3-phospho-L-serine (PS)(14, 15) . Analyses of the interaction of conventional PKC (cPKC) with membrane lipids support a two-step model for the activation of cPKC, which includes initial binding to membranes that does not require PS since cPKC binds various acidic phospholipids in a Ca-dependent manner and allosteric activation by specific interaction with PS and diacylglycerol(15) . The initial binding of cPKC to membranes is believed to be mediated by the Ca-dependent phospholipid-binding (CaLB) domain (amino acids 186-233 of PKC), a sequence motif that is also found in other cytosolic proteins such as cytosolic phospholipase A(2), GTPase-activating protein, and synaptotagmin(16, 17) . However, it has been difficult to validate the presence of the PS-specific binding site on PKC, since the enzyme interacts with multiple phospholipid molecules during activation. Our previous studies showed that the binding to PKC of the monoclonal anti-idiotypic antibody Id8F7 raised against the combining site of the PS-specific antibody is inhibited by PS but not by other phospholipids including the synthetic PS analogue, 1,2-diacyl-sn-glycero-3-phospho-D-serine (18, 19) . The binding of Id8F7 to PKC is significantly enhanced by the presence of diacylglycerol and is independent of the presence of Ca(19) . These observations indicate that Id8F7 binds to the PS-specific binding site, which is involved in the allosteric activation of PKC. In this study, we first mapped the Id8F7 binding site within the C2 region of rat PKC, and then we identified a 12-amino acid peptide motif responsible for the specific interaction with PS.


EXPERIMENTAL PROCEDURES

Materials

Among 34 anti-idiotypic monoclonal antibodies raised against the combining site of the PS-specific monoclonal antibody (PS4A7), one clone, Id8F7 (IgM, kappa), which showed an extensive cross-reaction with PKC, was used in this study(19) . PKC was purified to homogeneity as described previously(19) . Isopropyl-beta-D-thiogalactopyranoside, phenylmethylsulfonyl fluoride, Triton X-100, and 2-mercaptoethanol were purchased from Nacalai Tesque (Kyoto, Japan). Leupeptin and bovine serum albumin were purchased from Sigma. Other materials used are as described previously(18) .

Construction of PKC Fragment Expression Vectors

Recombinant fragments of rat PKC, PKC1-173 (amino acids 1-173 of the C1 region of the PKC) and PKC161-373 (amino acids 161-373 of the C2 region of the PKC), were expressed by plasmids referred to as pTB967 and pTB968, respectively(20) . PKC161-220 and PKC220-296 fragments were expressed as fused proteins with maltose binding protein. The cDNA fragments encoding PKC161-220 and PKC220-296 were obtained from pTB761, which contains the full coding sequence of rat PKC. The 2.9-kilobase EcoRI fragment excised out of pTB761 was digested with StuI, and the resultant 0.9-bp EcoRI-StuI fragment (1-1049; nucleotide sequence is numbered according to Ono et al.(21) ) was digested with HinfI and blunted by DNA polymerase I (large fragment) (Takara, Kyoto, Japan), followed by digesting with PstI. The 452-bp PstI-HinfI-filled fragment (nucleotides 345-798) and 232-bp HinfI-filled-PstI (nucleotides 798-1026) fragment were isolated. To express the PKC161-220, the PstI-HinfI-filled fragment was cloned in between the HindIII site blunted with DNA polymerase I (large fragment) and the PstI site of pMALc2 vector (New England Biolabs Inc., Beverly, MA). In order to remove the region overlapping PKC1-161, the resultant plasmid was digested with XmnI and AatII (nucleotide 617) and was blunted by T4 DNA polymerase I, followed by self-ligation. To express the PKC220-296, the HinfI-filled-PstI fragment was cloned in between the XmnI site and PstI site of pMALc2 vector. Each expression plasmid was introduced to Escherichia coli strain TB1 (New England Biolabs).

The transformant cells were cultured at 37 °C and were induced by addition of isopropyl-beta-D-thiogalactopyranoside to the final concentration of 0.5 mM. The cells were harvested by centrifugation after 3 h of incubation, and the cell pellets were resuspended in hypotonic buffer (HB; 20 mM Tris, 5 mM EDTA, 5 mM EGTA, 20 µg/ml leupeptin, 50 µg/ml phenylmethylsulfonyl fluoride, 10 mM 2-mercaptoethanol, pH 7.5). PKC1-173 and PKC161-373 were purified by consecutive washing with HB containing 1% Triton X-100 and 6 and 8 M urea. The final precipitates were dissolved in HB containing 6 M guanidine. PKC161-220 and PKC220-296 were resuspended in Tris-buffered saline (10 mM Tris, 150 mM NaCl, pH 7.4) containing 50 µg/ml phenylmethylsulfonyl fluoride and purified to homogeneity by affinity chromatography with amylose-resin (New England Biolabs). Expressed PKC fragments were at least 95% pure as judged by SDS-polyacrylamide gel electrophoresis. To confirm the amino acid sequences of the recombinant fragments, N-terminal amino acid sequences of each polypeptide were identified by amino acid sequencer (Applied Biosystems amino acid sequencer model 477A) after purification.

Identification of Id8F7 Binding Site on Rat PKC

The binding of Id8F7 to PKC and PKC fragments was examined by ELISA (19) . PKC (10 ng/well) or PKC fragments (50 ng/well) were coated onto the microtiter plate, and the binding of Id8F7 (5 µg/ml) was determined using biotinylated anti-mouse IgM (Zymed Laboratory, San Francisco, CA) and peroxidase-conjugated streptavidin (Zymed). One hundred µg of the PKC fragment, PKC220-296, which showed a strong reactivity with Id8F7, was digested with either Lys-C or Asp-N endoproteinase (Boehringer Mannheim, Germany) in Tris-buffered saline containing 1 M urea. After digestion for 2 h at 37 °C, the digested fragments were separated on reverse phase HPLC with an ODS-120T column (Tosoh, Japan) using a 5-80% acetonitrile linear gradient containing 0.1% trifluoroacetic acid. An aliquot of each fraction was coated onto microtiter wells, and the binding of Id8F7 to the plate-coated fragments was examined by ELISA as described above. The N-terminal amino acid sequences of the Id8F7-reactive peptide fragments were determined by the amino acid sequencer as described above. The synthetic peptides derived from the consensus sequence of PKC and PS decarboxylase (PSD) were synthesized using an automated peptide synthesizer (Advanced Chemtech, model 396 MPS), and an extra cysteine residue was added to the C-terminal end of the peptides(22) . The peptides were purified by reverse-phase HPLC with an ODS 120 column (Tosoh Co.). The sequence and molecular mass of each peptide were confirmed using an amino acid sequencer and JMS-HX110 double focusing mass spectrometer equipped with a fast atom bombardment ion source and a JMA-DA5000 data system (JEOL, Tokyo, Japan), respectively. The synthetic peptides (100 ng/well) were coated onto the microtiter plate by incubating for 12 h at 37 °C and incubated with Id8F7 (5 µg/ml). The binding of Id8F7 was determined as described above.

Binding of PKC Fragments and Synthetic Peptides to Phospholipids

The binding of PKC161-220 and PKC220-296 to various phospholipids was examined by ELISA. The wells of the microtiter plate were coated with 50 pmol/well of each phospholipid (18) and incubated with 5 µg/ml of the PKC fragments. The binding of the fragments to plate-coated phospholipids was determined using rabbit anti-maltose binding protein, IgG (New England Biolabs), and peroxidase-conjugated anti-rabbit IgG (Cappel, West Chester, PA). The binding of the synthetic peptides to phospholipids was determined by ELISA. In brief, alkaline phosphatase was activated with N-succinimidyl-3-(2-pyridyldithio)propionate (Pharmacia Biotech Inc.) (molar ratio of alkaline phosphatase to N-succinimidyl-3-(2-pyridyldithio)propionate of 1:8), followed by conjugation with the synthetic peptides via their cysteine residue (molar ratio of the peptides to the alkaline phosphatase of 36:1). According to this protocol, an average of three peptides was coupled to the alkaline phosphatase. The free peptides were removed by gel filtration with the PD-10 column (Pharmacia, Uppsala, Sweden), and the alkaline phosphatase-conjugated peptides (10 µg/ml) were incubated with the plate-coated phospholipids as described above. The binding of the peptides was determined by addition of 0.25 mM 4-methylumbelliferyl phosphate substrate solution(18) .


RESULTS AND DISCUSSION

To identify the PS-specific binding site on PKC, we mapped the Id8F7 binding site using recombinant and synthetic PKC fragments. The fragments covering the C1 region (amino acids 1-173, PKC1-173) and the C2 region (amino acids 161-373, PKC161-373) of PKC were expressed (Fig. 1A) (20) and examined for reactivity with Id8F7. Id8F7 bound effectively to PKC161-373 but not to PKC1-173 (Fig. 1B). Partial proteolytic digestion of PKC161-373 with endoproteinase Lys-C followed by separation and sequence analysis of the Id8F7-reactive peptides resulted in the identification of a single reactive peptide with the amino acid sequence, ATLNPVWNETFVFNLKPGDVER- - (single-letter amino acid code, from amino acid 217). The analysis using the endoproteinase Asp-N identified two Id8F7-reactive peptide fragments, DPYVKLKLIPDPRN- - - (from amino acid 193) and DPRNLTKQKTDTVKA- - - - (from amino acid 203). These results suggest that the Id8F7 binding site is either located in the CaLB domain (amino acids 186-242 of rat PKC) (17) or spanned to amino acids outside the CaLB domain. We expressed the fragments covering amino acids 161-220 (PKC161-220) and 220-296 (PKC220-296) in the C2 region (Fig. 1A) and showed that Id8F7 binds specifically to PKC220-296 (Fig. 1B). To study the functional role of this fragment, we examined the binding of the fragments to various phospholipids. PKC220-296 bound effectively to PS and showed some cross-reaction with phosphatidylinositol. PKC161-220 did not show any significant binding to the phospholipids (Fig. 2). These observations indicate that the PS-specific binding site recognized by Id8F7 is located in amino acids 220-296 in the C2 region of PKC.


Figure 1: Binding of anti-idiotypic monoclonal antibody Id8F7 to PKC fragments. A, schematic structure of rat brain PKC showing the four conserved regions (C1-C4) and the PKC fragments expressed in E. coli. B, the binding of Id8F7 to PKC and PKC fragments was examined by ELISA. PKC (10 ng/well) or PKC fragments (50 ng/well) were coated onto the microtiter plate, and binding of Id8F7 (5 µg/ml) was determined using biotinylated anti-mouse IgM and peroxidase-conjugated streptavidin. Bars represent the mean values of three different experiments.




Figure 2: Binding of PKC recombinant fragments to PS. The binding of PKC161-220 and PKC220-296 to various phospholipids was tested by ELISA. The wells of the microtiter plate were coated with 50 pmol/well of the phospholipids and incubated with 5 µg/ml of the PKC fragments. The binding of the fragments to plate-coated phospholipids was determined by rabbit anti-maltose binding protein IgG and peroxidase-conjugated anti-rabbit IgG. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; CL, cardiolipin.



We performed computer-aided similarity searching (SDC-GENETYX program, Software Development, Tokyo) for amino acid sequences in PKC220-296 and PSD from Chinese hamster ovary (CHO) cell(23) , the only example of the enzyme that has been shown to specifically recognize the molecular structure of PS(23, 24) . The analysis revealed significant homology between the primary sequences of PKC (amino acids 227-238) and PSD (amino acids 351-362) (Fig. 3A). The consensus sequence is conserved among the cPKC family from different species(1) . We synthesized various peptides derived from the consensus sequence of PKCs and PSD to determine whether the consensus sequence is responsible for the interaction with Id8F7. Id8F7 bound effectively to the synthetic peptides derived from both PKC and PSD (Fig. 3B). Deletion of the FXF residue greatly reduced reactivity, and replacement of the consensus lysine or arginine residues with alanine also reduced reactivity (Fig. 3B). The results indicate that Id8F7 recognizes the peptide motif with the consensus FXFXLKXXXKXR amino acid sequence.


Figure 3: Identification of Id8F7-binding peptide sequence on PKC and PSD. A, comparison of amino acid sequences shared by rat PKC family and PSD from CHO cells. Conserved amino acid residues are indicated by boldface letters, with residue numbers on the right. Searching for similar amino acid sequences was performed using the SDC-GENETYX program (Software Development, Tokyo). B, binding of Id8F7 to the synthetic peptides derived from the consensus sequence of PKC and PSD. The synthetic peptides (100 ng/well) were coated onto the microtiter plate by incubating for 12 h at 37 °C and incubated with Id8F7 (5 mg/ml). Binding of Id8F7 was determined using biotinylated anti-mouse IgM and peroxidase-conjugated streptavidin.



To assess the functional role of the consensus sequence, we examined the binding of each synthetic peptide to various phospholipids. In this assay, each peptide was conjugated with alkaline phosphatase, and its binding to plate-coated phospholipids was examined by ELISA. Among the synthetic peptides examined, the peptide derived from PSD (FNFRLKAGQKIRFG) bound effectively and specifically to PS, and the peptide derived from PKC (FVFNLKPGDVERRL) bound weakly to PS (Fig. 4, A and B). The peptide derived from PKCbeta (FRFQLKESDKDRRL) tends to adhere nonspecifically to the plate-coated phospholipids, but it bound effectively to PS when the lower concentration of phospholipids was used to coat the wells of microtiter plates (Fig. 4C). No significant binding of the other synthetic peptides to the phospholipids was observed (data not shown). Since the binding of the peptides to PS correlates well with their binding to Id8F7, it is likely that the conserved amino acid residues, FXFXLKXXXKXR, in the consensus sequence also play a dominant role in the interaction with PS.


Figure 4: Specific binding of 14 amino acids synthetic peptides to PS. Synthetic peptides, FNFRLKAGQKIRFGC from PSD (A) and FVFNLKPGDVERRLC from PKC (B), were conjugated to alkaline phosphatase as described under ``Experimental Procedures.'' The alkaline phosphatase-conjugated peptides (10 µg/ml) were incubated with the plate-coated phospholipids (50 pmol/well for A and B and 5 pmol/well for C), and the binding of the peptides was determined by the addition of 0.25 mM 4-methylumbelliferyl phosphate substrate solution.



The PSD, which catalyzes the conversion of PS to phosphatidylethanolamine, has been isolated from CHO cell(23) , E. coli(25) , and yeast(26, 27) . The consensus sequence motif observed in the PSD of CHO cell is conserved in the yeast PSD (amino acids 475-486, FKFDVRVGDKVK) but not in the E. coli enzyme. PSD is a pyruvoyl-dependent enzyme, and the post-translational cleavage of a proenzyme (-subunit) is believed to form the pyruvoyl prosthetic group at the N terminus of the alpha subunit, which is composed of the C-terminal 32 amino acids of the PSD of CHO cells and 38 amino acids of the yeast enzyme(23, 26, 27) . It is noteworthy here that the consensus sequences in yeast and mammalian PSD are located in the alpha subunit of the enzyme, which are close to the catalytic carbonyl group of the enzyme. Recently, Trotter et al. (28, 29) isolated the structural gene encoding the second PSD gene (PSD2) from yeast. The PSD2 amino acid sequence contains a region of about 40 residues from 534 to 577 with high homology to the C2 regions of PKC (amino acids 211-254 of rat PKC) and the two C2 regions of synaptotagmin(29) . Trotter et al.(29) suggested that this C2 homology domain represents a phospholipid-binding motif of these proteins. The present consensus sequence motif of rat PKC (amino acids 227-238) resides in the C2 homology domain, and the similar sequence motif is also identified in PSD2 (amino acids 561-572) but not in synaptotagmins. Since PKC (14, 15) and PSD2 (29) were shown to interact specifically with PS but synaptotagmin binds nonspecifically to various acidic phospholipids (16) , the consensus sequence between PKC and PSD, FXFX(I/V/L)(K/R)XX(D/Q)K, is likely to mediate the specific interaction of these proteins with PS.

The present study provides the first structural information of polypeptides responsible for the specific interaction with PS. Since the 14-amino acid synthetic peptides derived from PS decarboxylase bound effectively and specifically to PS, the corresponding region may form the substrate recognition site of the enzyme. The results using the synthetic peptides suggest that the conserved amino acid residues among PKC and CHO cell PSD, FXFXLKXXXKXR, which are recognized by the anti-idiotypic antibody, represent a basic structural motif for the specific interaction with PS. Computer-aided similarity searching showed that various cellular proteins have a homologous sequence motif; typical examples are DNA topoisomerase IIalpha (amino acids 1022-1033)(30, 31) , spectrin alpha (amino acids 1598-1609)(32) , calmodulin-sensitive adenylate cyclase (amino acids 148-159)(33) , complement receptor type II (amino acids 381-392)(34) , urinary fatty acid binding protein (amino acids 73-86)(35) , Dengue virus non-structural protein NS2A (amino acids 1332-1343)(36) , and RNA polymerase beta subunit (amino acids 2108-2119)(37) . Among these proteins, rat DNA topoisomerase IIalpha isolated from mouse fibroblast cell line FM3A and spectrin purified from human red blood cells were recently shown to bind effectively to Id8F7. The binding of Id8F7 to these proteins was specifically inhibited by the preincubation of the proteins with PS, suggesting that these proteins have a specific binding site for PS. (^2)Although further investigations are required to determine the structure and biological significance of the consensus sequence motif, the motif may represent a putative PS-specific binding motif commonly present in cellular proteins. The anti-idiotypic antibody will serve as a useful tool for identifying PS-binding proteins and locating PS-specific binding sites, which have been difficult to determine by the conventional biochemical techniques.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 81-3-3823-2101 (ext. 5419); Fax: 81-3-3823-2965; umeda@rinshoken.or.jp.

(^1)
The abbreviations used are: PS, phosphatidylserine; PKC, protein kinase C; cPKC, conventional PKC; CaLB, Ca-dependent phospholipid binding; bp, base pair(s); HB, hypotonic buffer; ELISA, enzyme-linked immunosorbent assay; HPLC, high pressure liquid chromatography; PSD, PS decarboxylase; CHO, Chinese hamster ovary.

(^2)
M. Kaneda, K. Igarashi, A. Yamaji, K. Inoue, and M. Umeda, manuscript in preparation.


ACKNOWLEDGEMENTS

We thank Dr. Yasutomi Nishizuka for helpful discussion and encouragement during the course of this work.


REFERENCES

  1. Nishizuka, Y. (1992) Science 258, 607-611 [Medline] [Order article via Infotrieve]
  2. Bell, R. M., and Burns, D. J. (1991) J. Biol. Chem. 266, 4661-4664 [Free Full Text]
  3. Newton, A. C., and Keranen, L. M. (1994) Biochemistry 33, 6651-6658 [Medline] [Order article via Infotrieve]
  4. Mann, K. G., Jenny, R. J., and Krishnaswamy, S. (1988) Annu. Rev. Biochem. 57, 915-956 [CrossRef][Medline] [Order article via Infotrieve]
  5. Comfurius, P., Smeets, E. F., Willems, G. M., Bevers, E. M., and Zwaal, R. F. A. (1994) Biochemistry 33, 10319-10324 [Medline] [Order article via Infotrieve]
  6. Gilbert, G. E., and Drinkwater, D. (1993) Biochemistry 32, 9577-9585 [Medline] [Order article via Infotrieve]
  7. Ghosh, S., Xie, W. Q., Quest, A. F. G., Mabrouk, G. M., Strum, J. C., and Bell, R. M. (1994) J. Biol. Chem. 269, 10000-10007 [Abstract/Free Full Text]
  8. Calderon, C. H., Huang, Z-H., Gage, D. A., Sotomayor, E. M., and Lopez, D. M. (1994) J. Exp. Med. 180, 945-958 [Abstract]
  9. Stekhoven, F. M. A. H. S., Tijmes, J., Umeda, M., Inoue, K., and De Pont, J. J. H. M. (1994) Biochim. Biophys. Acta 1194, 155-165 [Medline] [Order article via Infotrieve]
  10. Tuma, P. L., Stachniak, M. C., and Collins, C. A. J. (1993) J. Biol. Chem. 268, 17240-17246 [Abstract/Free Full Text]
  11. Sakane, F., Yamada, K., Imai, S., and Kanoh, H. (1991) J. Biol. Chem. 266, 7096-7100 [Abstract/Free Full Text]
  12. Fadok, V. A., Laszlo, D. J., Noble, P. W., Weinstein, L., Riches, D. W. H., and Henson, P. M. (1993) J. Immunol. 151, 4274-4285 [Abstract/Free Full Text]
  13. Connor, J., Pak, C. C., and Schroit, A. J. (1994) J. Biol. Chem. 269, 2399-2404 [Abstract/Free Full Text]
  14. Lee, M. H., and Bell, R. M. (1989) J. Biol. Chem. 264, 14797-14805 [Abstract/Free Full Text]
  15. Orr, J. W., and Newton, A. C. (1992) Biochemistry 31, 4667-4673 [Medline] [Order article via Infotrieve]
  16. Perin, M. S., Fried, V. A., Mignery, G. A., Ahn, R., and Sudhof, T. C. (1990) Nature 345, 260-263 [CrossRef][Medline] [Order article via Infotrieve]
  17. Clark, J. D., Lin, L. L., Kriz, R. W., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N., and Knopf, J. L. (1991) Cell 65, 1043-1051 [Medline] [Order article via Infotrieve]
  18. Umeda, M., Igarashi, K., Nam, K. S., and Inoue, K. (1989) J. Immunol. 143, 2273-2279 [Abstract/Free Full Text]
  19. Reza, F., Igarashi, K., Tokita, S., Asai, K., Asaoka, Y., Umeda, M., and Inoue, K. (1994) FEBS Lett. 339, 229-233 [CrossRef][Medline] [Order article via Infotrieve]
  20. Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa, U., and Nishizuka, Y. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4868-4871 [Abstract]
  21. Ono, Y., Fujii, T., Igarashi, K., Kikkawa, U., Ogita, K., and Nishizuka, Y. (1988) Nucleic Acids Res. 16, 5199-5200 [Medline] [Order article via Infotrieve]
  22. Igarashi, K., Asai, K., Kaneda, M., Umeda, M., and Inoue, K. (1995) J. Biochem. (Tokyo) 117, 452-457 [Abstract]
  23. Kuge, O., Nishijima, M., and Akamatsu, Y. (1991) J. Biol Chem. 266, 6370-6376 [Abstract/Free Full Text]
  24. Dowhan, W., and Li, Q-X. (1992) Methods Enzymol. 209, 348-359 [Medline] [Order article via Infotrieve]
  25. Li, Q.-X., and Dowhan, W. (1993) J. Biol. Chem. 263, 11516-11522 [Abstract/Free Full Text]
  26. Trotter, P. J., Pedretti, J., and Voelker, D. R. (1993) J. Biol. Chem. 268, 21416-21424 [Abstract/Free Full Text]
  27. Constance, J. C., Chang, S.-C., and Dowhan, W. (1993) J. Biol. Chem. 268, 24580-24590 [Abstract/Free Full Text]
  28. Trotter, P. J., and Voelker, D. R. (1995) J. Biol. Chem. 270, 6062-6070 [Abstract/Free Full Text]
  29. Trotter, P. J., Pedretti, J., Yates, R., and Voelker, D. R. (1995) J. Biol. Chem. 270, 6071-6080 [Abstract/Free Full Text]
  30. Adachi, N., Miyaike, M., Ikeda, H., and Kikuchi, A. (1992) Nucleic Acids Res. 20, 5297-5303 [Abstract]
  31. Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. W., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C. M., and Wang, J. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7177-7181 [Abstract]
  32. Dubreuil, R. R., Byers, T. J., Sillman, A. L., Bay-Zvi, D., Goldstein, L. S. B., and Branton, D. (1989) J. Cell Biol. 109, 2197-2205 [Abstract]
  33. Glaser, P., Ladant, D., Sezer, O., Pichot, F., Ullmann, A., and Danchin, A. (1988) Mol. Microbiol. 2, 19-30 [Medline] [Order article via Infotrieve]
  34. Fujisaki, A., Harley, J. B., Frank, M. B., Gruner, B. A., Frazier, B., and Holers, V. M. (1989) J. Biol. Chem. 264, 2118-2125 [Abstract/Free Full Text]
  35. Unterman, R. D., Lynch, K. R., Nakhasi, H. L., Dolan, K. P., Hamilton, J. W., Cohn, D. V., and Feigelson, P. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 3478-3482 [Abstract]
  36. Osatomi, K., and Sumiyoshi, H. (1990) Virology 176, 643-647 [Medline] [Order article via Infotrieve]
  37. Galinski, M. S., Mink, M. A., and Pron, M. W. (1988) Virology 165, 499-510 [CrossRef][Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.